Insider Trading History of Ollier Michele

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Ollier Michele since 2010. The trader's CIK number is 1503685. At the time of the last reporting, Ollier Michele was the Director of Minerva Neurosciences, Inc.. (stock ticker symbol NERV). Also see all insider trading activities at Minerva Neurosciences, Inc..

Note that in the past Ollier Michele also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aegerion Pharmaceuticals, Inc. (AEGR) by Ollier Michele

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 AEGR 0 $0 877,723 $12,822,655 0 $0
2010 AEGR 315,789 $2,999,995 0 $0 0 $0

Yearly summary of insider trading at Minerva Neurosciences, Inc. (NERV) by Ollier Michele

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 NERV 0 $0 1,000,000 $10,000,000 0 $0
2015 NERV 202,634 $974,669 0 $0 0 $0
2014 NERV 1,620,833 $9,724,998 0 $0 0 $0


Insider trading activities at 2 companies by Ollier Michele:

1. Aegerion Pharmaceuticals, Inc. (AEGR)

2. Minerva Neurosciences, Inc. (NERV)

Table 1. Insider trading of Aegerion Pharmaceuticals, Inc. (AEGR) by Ollier Michele

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-06-29 AEGR Sale 877,723 14.61 12,822,655
2010-10-27 AEGR Buy 315,789 9.50 2,999,995

Table 2. Insider trading of Minerva Neurosciences, Inc. (NERV) by Ollier Michele

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-08-10 NERV Sale 1,000,000 10.00 10,000,000
2015-03-18 NERV Buy 202,634 4.81 974,669
2014-07-07 NERV Buy 1,620,833 6.00 9,724,998

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ollier Michele (Director of Minerva Neurosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.